Follow
Jean-Christophe Bélisle-Pipon
Jean-Christophe Bélisle-Pipon
Faculty of Health Sciences, Simon Fraser University
Verified email at sfu.ca - Homepage
Title
Cited by
Cited by
Year
Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries
JC Bélisle-Pipon, E Vayena, R C. Green, IG Cohen
Nature Medicine, 2019
372019
Early-career researchers’ views on ethical dimensions of patient engagement in research
JC Bélisle-Pipon, G Rouleau, S Birko
BMC medical ethics 19 (1), 1-10, 2018
312018
Patients as Research Partners; How to Value their Perceptions, Contribution and Labor?
E Smith, JC Bélisle-Pipon, D Resnik
Citizen Science 4 (1), 1-13, 2019
302019
Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information
JC Bélisle Pipon, B Williams-Jones
Journal of Bioethical Inquiry 12 (2), 259-267, 2015
192015
Duty to inform and informed consent in diagnostic radiology: how ethics and law can better guide practice
V Doudenkova, JC Bélisle Pipon
Hec forum 28 (1), 75-94, 2016
132016
Regulating Direct-to-Consumer Drug Information: A Case Study of Eli Lilly’s Canadian 40over40 Erectile Dysfunction Campaign
JC Bélisle Pipon, B Williams-Jones
Healthcare Policy 10 (4), 16-22, 2015
122015
Early career researchers’ perspectives and roles in patient-oriented research
G Rouleau, JC Bélisle-Pipon, S Birko, P Karazivan, N Fernandez, ...
Research Involvement and Engagement 4 (1), 1-15, 2018
102018
Merging arts and bioethics: An interdisciplinary experiment in cultural and scientific mediation
V Couture, JC Bélisle-Pipon, M Cloutier, C Barnabé
Bioethics, 616–630, 2017
72017
Ethics education in public health: where are we now and where are we going?
V Doudenkova, JC Bélisle-Pipon, L Ringuette, V Ravitsky, ...
International Journal of Ethics Education, 2017
72017
Protecting public health or commercial interests? The importance of transparency during immunization campaigns
JC Bélisle-Pipon, L Ringuette, V Doudenkova, B Williams-Jones
Ethics, Medicine and Public Health, 2017
62017
Preparing for the arrival of “pink Viagra”: strengthening Canadian direct-to-consumer information regulations
JC Bélisle Pipon, B Williams-Jones
Canadian Medical Association Journal 188 (5), 319-320, 2016
6*2016
De la binarité au modèle AI3R : la bioéthique écosystémique comme modèle d’analyse normative de l’industrie biopharmaceutique
JC Bélisle Pipon
Université de Montréal, 2013
62013
Experts sous influence? Quand la non-divulgation des conflits d’intérêts met à risque la confiance du public
B Williams-Jones, JC Bélisle-Pipon, L Ringuette, AI Cloutier, ...
Autour de l’intégrité scientifique, la loyauté, et la probité : aspects …, 2016
52016
Ethical challenges of open
B Williams-Jones, JC Belisle Pipon, E Smith, R Boulanger
Access Publishing. tinyurl. com/p5652d6 (Last accessed: June 8 2015.), 2014
52014
Conflicts of interest and the (in)dependence of experts advising government on immunization policies
JC Bélisle-Pipon, L Ringuette, AI Cloutier, V Doudenkova, ...
Vaccine, 2018
42018
Patients with “dates”: Wrong for doctors but acceptable for drug companies?
JC Bélisle-Pipon
Bioethics Update 6 (1), 7-16, 2020
32020
“What Is PER?” Patient Engagement in Research as a Hit
JC Bélisle-Pipon, C Del Grande, G Rouleau
Canadian Journal of Bioethics 1 (2), 59-62, 2018
32018
Using Social Media to Sell Prescription Drugs
JC Bélisle-Pipon, S Birko
Impact Ethics, 2017
32017
Améliorer la compréhension et la gestion des conflits d’intérêts des experts conseillant la prise de décisions en santé publique
AI Cloutier, JC Bélisle-Pipon, L Ringuette, V Doudenkova, ...
BioéthiqueOnline 5 (38), 1-5, 2016
32016
Les enjeux éthiques de la limite des ressources en santé
J Saint-Arnaud, B Godard, JC Bélisle Pipon
Presses de l'Université de Montréal, 2016
32016
The system can't perform the operation now. Try again later.
Articles 1–20